Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Reuven Or, MD"
3,829
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT02117362
Completed
Phase 1
Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma
Galectin Therapeutics Inc.
ClinicalTrials.gov
NCT02117362
Completed
Phase 1
Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanom...
Galectin Therapeutics Inc...
NCT03652051
Completed
Phase 2
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
Azura Ophthalmics
ClinicalTrials.gov
NCT03652051
Completed
Phase 2
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfu...
Azura Ophthalmics
NCT01901913
Completed
Not Applicable
MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management
Rabin Medical Center
ClinicalTrials.gov
NCT01901913
Completed
Not Applicable
MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management
Rabin Medical Center
NCT06781554
Recruiting
Not Applicable
Evaluation of the Performance and Safety of a Type I Collagen-Based Medical Device (MD-Small Joints Collagen Medical Device) i the Treatment of RHIZOARTROSIS
Guna S.p.a
ClinicalTrials.gov
NCT06781554
Recruiting
Not Applicable
Evaluation of the Performance and Safety of a Type I Collagen-Based Medical Devi...
Guna S.p.a
NCT01157923
Completed
Not Applicable
MD Logic Pump Advisor- Adults Study
Medtronic
ClinicalTrials.gov
NCT01157923
Completed
Not Applicable
MD Logic Pump Advisor- Adults Study
Medtronic
NCT07431112
Recruiting
Phase 1
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
Airna Corp.
ClinicalTrials.gov · CTIS (EMA)
NCT07431112
Recruiting
Phase 1
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
Airna Corp.
NCT01238406
Completed
Not Applicable
Overnight MD-Logic
Rabin Medical Center
ClinicalTrials.gov
NCT01238406
Completed
Not Applicable
Overnight MD-Logic
Rabin Medical Center
NCT02462967
Completed
Phase 2
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Dr. Naga Chalasani, MD, Indiana University
ClinicalTrials.gov
NCT02462967
Completed
Phase 2
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatme...
Dr. Naga Chalasani, MD, I...
NCT03972501
Completed
Phase 2
An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)
Azura Ophthalmics
ClinicalTrials.gov
NCT03972501
Completed
Phase 2
An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) o...
Azura Ophthalmics
NCT04391959
Completed
Phase 2
Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)
Avania
ClinicalTrials.gov
NCT04391959
Completed
Phase 2
Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)
Avania
NCT00258193
Completed
Phase 2
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
Ironwood Pharmaceuticals, Inc.
ClinicalTrials.gov
NCT00258193
Completed
Phase 2
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-...
Ironwood Pharmaceuticals,...
NCT00857168
Completed
Phase 1
To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion
Acrux DDS Pty Ltd
ClinicalTrials.gov
NCT00857168
Completed
Phase 1
To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmac...
Acrux DDS Pty Ltd
NCT01308164
Completed
Not Applicable
MD Logic Pump Advisor -Pediatric Study
Medtronic
ClinicalTrials.gov
NCT01308164
Completed
Not Applicable
MD Logic Pump Advisor -Pediatric Study
Medtronic
NCT02733211
Withdrawn
Not Applicable
Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
GIF
ClinicalTrials.gov
NCT02733211
Withdrawn
Not Applicable
Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Contro...
GIF
NCT04166058
Completed
Phase 3
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
AbbVie
ClinicalTrials.gov
NCT04166058
Completed
Phase 3
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
AbbVie
NCT06615518
Completed
Not Applicable
Comparison of Clinical Effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in Patients With Lumbar Disc Herniation
University of Opole
ClinicalTrials.gov
NCT06615518
Completed
Not Applicable
Comparison of Clinical Effectiveness of Full Endoscopic Lumbar Discectomy (FELD)...
University of Opole
NCT06961682
Not Yet Recruiting
Not Applicable
Effectiveness of MD on MetS Patients
Assiut University
ClinicalTrials.gov
NCT06961682
Not Yet Recruiting
Not Applicable
Effectiveness of MD on MetS Patients
Assiut University
NCT00404001
Completed
Phase 2
Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Ironwood Pharmaceuticals, Inc.
ClinicalTrials.gov
NCT00404001
Completed
Phase 2
Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Ironwood Pharmaceuticals,...
NCT00857454
Completed
Phase 3
A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations
Eli Lilly and Company
ClinicalTrials.gov
NCT00857454
Completed
Phase 3
A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulatio...
Eli Lilly and Company
NCT00857961
Completed
Phase 2
A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations
Eli Lilly and Company
ClinicalTrials.gov
NCT00857961
Completed
Phase 2
A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formula...
Eli Lilly and Company
Result Breakdown
Status
Completed
16 (80%)
Recruiting
2 (10%)
Withdrawn
1 (5%)
Not yet recruiting
1 (5%)
Phase
not_applicable
8 (40%)
Phase 2
7 (35%)
Phase 1
3 (15%)
Phase 3
2 (10%)
Top Conditions
Type 1 Diabetes
5 (25%)
Hypogonadism
3 (15%)
Meibomian Gland Dysfunction
2 (10%)
Show 7 more
Top Sponsors
Rabin Medical Center
5 (25%)
Azura Ophthalmics
3 (15%)
Ironwood Pharmaceuticals, Inc.
3 (15%)
Show 7 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease